Search 

Henlius (2696.HK) is a leading biopharmaceutical company in China with the vision to offer high-quality, affordable and innovative biologics for patients worldwide with a focus on oncology and autoimmune diseases. Since its inception in 2010, Henlius has built an integrated and efficient global R&D platform with key facilities in Shanghai, Taipei and California, and commercial office in Frankfurt. The three R&D centers closely collaborate with each other to ensure a highly productive and cost-efficient R&D process.
Starting from biosimilar, Henlius presses forward with novel mAb products and immuno-oncology combination therapies with proprietary anti-PD-1 and PD-L1 mAbs as backbone. Henlius establishes a diversified product pipeline of biosimilars, bio-innovative drugs and combination therapies, and builds an integrated platform covering the whole product lifecycle including R&D, commercial-scale production and commercialization.

Keywords : Cancer, Oncology, Biologics, Biosimilar, BioInnovative, Biobetter, Monoclonal Antibody, Mabs, Tumors, Immuno oncology, PD1, PD-L1, EGFR, VEGF, HER2,

Our company focUnited Statesed on innovative drug discovery,Sticking to indevelop R&D,and we have very robUnited Statest pipeline and flexible bUnited Statesiness model.

SIRC is specialized in natural drug discovery from Chinese Medicine. It has a TCM data base including 270,000 prescriptions, 9,000 herbs and 50,000 herb-derived compounds. We provide the customized drug discovery based on natural herbs.

J Rich Capital Inc. is an investment banking boutique with offices in Shanghai and Silicon Valley. Established in 2008, we specialize in mergers and acquisitions, capital raising, and asset management services within biotech, pharmaceutical, and real estate industries. Our expansive capital management capabilities as well as our deep understanding of the China market differentiate us from our peers in the financial industry.

Shanghai Junshi

digital healthcare company

CRO based in Shanghai

Top medical device company in China focused on cardiovascular, surgical robotics and ten more fields.

China top 3 pharma company in both commercialization and manufacturing sales. Dual listed on HK and Shanghai stock exchange market .

Founded in 2007, T&W Group specializes in developing, manufacturing and supplying fine chemicals in Pharmaceuticals, Agrochemicals, Photosensitive Materials, UV Curing Coatings, Brightener, OLED & Electronic Chemicals and other specialty chemicals. We also have R&D center focusing on CDMO projects for our customer.